Home » Newsletters » BioWorld Science

BioWorld Science

June 27, 2006

View Archived Issues

Pharmacokinetic and clinical studies of the insomnia treatment gaboxadol presented

Ceragenix enters agreement for formulation work of CSA-13 nasal ointment

Mayne Pharma acquires SuperGen's North American oncology products

Enrollment completed in follow-up study for Pollinex Quattro allergy vaccine

IND approval for Neocartilage clinical trials

Phase II SBIR grant for preclinical work on Panacea's stroke drug

QuatRx licenses 17-beta HSD-1 inhibitors from Solvay

Celera Genomics and Medarex collaborate on therapeutic antibodies in cancer

Otoprotective drug AM-111 shows benefit in acute sensorineural hearing loss

Riquent MAA accepted for review in Europe

Targeting the dopamine D3 receptor to block the reinforcing efficacy of nicotine

Johnson & Johnson report on new candidates for excessive daytime sleepiness disorders

Daily dosing with PR-171 shown safe and effective in cancer animal models

Neurocrine and Pfizer terminate indiplon collaboration

CE Mark for Cypher Select PLUS

AV-650 cleared to begin U.S. clinical trials

Phase III studies of sarizotan fail to meet primary efficacy endpoint

Recordati inlicenses Infasurf for E.U.

Proof-of-concept study begins for pagoclone in premature ejaculation

Acapodene may lower cholesterol in men receiving androgen deprivation therapy

Molecular docking studies of bosutinib identify residues essential for stable binding

Inhibition of FAAH modulates sleep patterns by increasing brain endocannabinoids

Preclinical and preliminary clinical antidiabetic profiles of the novel, DPP-IV inhibitor GRC-8200

N-5984 pharmacokinetics, safety and efficacy in healthy subjects and obese, diabetic patients

Preclinical antidiabetic efficacy and pharmacokinetics of the DPP-IV inhibitor, SYR-322

Novartis seeks Japanese approval of Xolair

Lilly files for Japanese approval of pemetrexed for malignant pleural mesothelioma

Wyeth files NDAs for women's health therapies

Recent patents impart new anticancer agents

New gastric acid antisecretory agents emerge from Altana Pharma R&D

New agents for neurological disorders subject of recent patents

Cyclohexanehexol Abeta inhibitors from Transition Therapeutics improve cognition in vivo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...